Back to search
ICAD - Intracranial Atherosclerotic Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ICAD - Intracranial Atherosclerotic Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ICAD - Intracranial Atherosclerotic Disease trials you may qualify forIntracranial atherosclerotic disease is the most common cause of ischemic stroke that is directly attributed to the progression or rupture of intracranial high-…
The purpose of the study are: 1. To make quality, characterized samples and related data available for future studies, including Genome Wide Association Studie…
Intracranial atherosclerotic stenosis (ICAS) carries substantial stroke risk despite optimal medical treatment. Current risk stratification relies primarily on…
Stroke is an important cause of death, disability, and memory problems in adults. The build-up of plaque in arteries inside the brain is known as "intracranial…
This study will explore the safety and efficacy of BASIS technology in ICAS-LVO lesions through a multicenter, prospective, registry, observational single-arm s…
The aim of DREAM-PRIDE is to evaluate whether implantation of drug-eluting stent (DES) combined with aggressive medical treatment is more efficacious in prevent…
The goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptom…
Narrowing of the carotid artery due to atherosclerosis with an unstable plaque can cause a stroke. Patients with carotid artery disease who have had a TIA or mi…
The cerebral and spinal vasculature possesses several unique properties: it is composed of relatively small vessels, it has a highly connected network architect…